{"id":"https://genegraph.clinicalgenome.org/r/059f7868-5e5e-405c-9679-511d1e9bd688v1.0","type":"EvidenceStrengthAssertion","dc:description":"There has been sufficient evidence published associating the MSH6 gene with constitutional mismatch repair deficiency syndrome - a distinct disorder from Lynch syndrome -  since the gene-disease relationship was first proposed by Menko, et al., (2004). Multiple case level studies have been performed with cMMRD patients that have variants in the MSH6 gene. Other mismatch repair (MMR) genes MLH1, MSH2 and PMS2 also causes constitutional mismatch repair deficiency syndrome. IHC and western blot revealed absence of MSH6 protein in patient cells. Multiple MSH6 deficient mouse and zebrafish models have been established to show consistent phenotypes with MMRCS patients by developing neurofibromas, non-Hodgkin’s lymphoma (NHL) and gastrointestinal (GI) tumors. All of these types of evidence are consistent with a definitive relationship between the MSH6 gene and constitutional mismatch repair deficiency syndrome.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/059f7868-5e5e-405c-9679-511d1e9bd688","GCISnapshot":"https://genegraph.clinicalgenome.org/r/b7d02927-ac93-4a43-a86d-01cd381f4e9f","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/b7d02927-ac93-4a43-a86d-01cd381f4e9f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/b7d02927-ac93-4a43-a86d-01cd381f4e9f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-10-09T14:57:26.378Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7d02927-ac93-4a43-a86d-01cd381f4e9f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f59c857c-e5f2-48dc-bd40-dffaa253b7ba_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 1-bp insertion (1596insT) in exon 4 and a 1-bp deletion (3261delC; 600678.0017) in exon 5, both resulting in frameshifts and premature protein truncation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aed92b6d-a776-4d64-8298-1756bb2c1c55","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","rdfs:label":"The 9-year-old youngest girl","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0100843","obo:HP_0005227","obo:HP_0000957"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f59c857c-e5f2-48dc-bd40-dffaa253b7ba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","allele":[{"id":"https://genegraph.clinicalgenome.org/r/74128630-cb59-40ab-a956-672815876dc8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"MSH6, 1-BP DEL, 3261C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8943"}},{"id":"https://genegraph.clinicalgenome.org/r/066539a0-4f6d-4b0a-add1-d1ce09b38df2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"MSH6, 1-BP INS, 1596T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8942"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/07285baa-1ed5-471a-a065-e40089de8834_proband_score_evidence_line","type":"EvidenceLine","dc:description":"In the colon ascendens and the normal colonic mucosa, there were exclusive loss of the MSH6 protein (Figure 1). The MSH6 mutation, c.1806_1809delAAAG; p.Glu604-LeufsX5 in exon 4, is predicted to result in a frameshift and premature stop codon after four amino acids. The second MSH6 mutation, c.3226C>T; p.Arg1076Cys in exon 5, is predicted to result in the substitution of cystein for arginine at amino acid position 1076. Both variants are three star variants reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e682e299-8c47-497d-8918-89db8bc15765","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18409202","rdfs:label":"The patient","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":16,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001045","obo:HP_0003003","obo:HP_0002725"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/07285baa-1ed5-471a-a065-e40089de8834_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18409202","allele":[{"id":"https://genegraph.clinicalgenome.org/r/e221a3f5-2ec1-4840-a1cf-8f5ebe31b7d9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000179.2(MSH6):c.1806_1809delAAAG (p.Glu604Leufs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/89224"}},{"id":"https://genegraph.clinicalgenome.org/r/dd71276b-4f31-4f5f-8dd2-a7d7994eb964","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000179.2(MSH6):c.3226C>T (p.Arg1076Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/89357"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/00d73517-ce41-46a0-8f9b-0ab88a29d616_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A homozygous 3-bp deletion (3386_3388delGTG) in exon 5 of the MSH6 gene, resulting in a frameshift. It is a three star variant reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c889501a-5d4c-4126-9d11-b60bb8af4bea","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15340263","rdfs:label":"V:4","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":10,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0100706","obo:HP_0000957","obo:HP_0003003"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/00d73517-ce41-46a0-8f9b-0ab88a29d616_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15340263","allele":{"id":"https://genegraph.clinicalgenome.org/r/1879ff0a-c587-433c-a487-462a8f0926e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000179.2(MSH6):c.3386_3388delGTG (p.Cys1129_Val1130delinsLeu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/89379"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/98fd3317-f6cc-4a0c-b5de-60bdc72fdf0e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Immunohistochemical analysis of a colonic adenoma biopsy sample showed normal staining for MSH2 and MLH1, but absence of staining for MSH6. The paternally inherited mutation (c.642C>G) produces a stop codon in exon 4 (p.Y214X), and the maternally inherited mutation (c.458–1G>A) disrupts the invariant guanine residue at the splice acceptor site of exon 3. Both variants are three star variants reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fcccf36e-9e31-45ef-9ba8-6622ea551a1e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17259933","rdfs:label":"A 13-year-old girl","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0003003","obo:HP_0005227","obo:HP_0004808","obo:HP_0002885"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/98fd3317-f6cc-4a0c-b5de-60bdc72fdf0e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17259933","allele":[{"id":"https://genegraph.clinicalgenome.org/r/9cc9e993-62a4-41cf-9b5a-cc13e76a20e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000179.2(MSH6):c.458-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/89531"}},{"id":"https://genegraph.clinicalgenome.org/r/d32423c1-49e8-49bc-ae6b-5286422bb840","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000179.2(MSH6):c.642C>G (p.Tyr214Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/89547"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ca433587-b7f8-4391-9622-61190903d577_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 3073G-A transition resulting in a trp1024-to-ter (W1024X) substitution, and a 3-bp deletion (3609_3612del).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82a53402-98b8-404d-be54-5d77373d0cce","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16283678","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":9,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000957","obo:HP_0012190","obo:HP_0009592","obo:HP_0100843","obo:HP_0000997"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ca433587-b7f8-4391-9622-61190903d577_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16283678","allele":[{"id":"https://genegraph.clinicalgenome.org/r/77de0f44-65cf-4937-a3df-54c938e1163b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"MSH6, TRP1024TER","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8938"}},{"id":"https://genegraph.clinicalgenome.org/r/ff9e85f9-5580-4535-a5a4-e1149761b36e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"MSH6, 3-BP DEL, NT3609","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8939"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7d1c61f5-10f1-4bfa-8400-f90d5be47308_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A homozygous 1-bp insertion (3436insT) in exon 7 of the MSH6 gene, resulting in a truncated protein missing the last 179 amino acids.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8a6c276-179c-4e1e-91a7-2a259623953c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16000562","rdfs:label":"IV-1","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":9,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000997","obo:HP_0040276","obo:HP_0012190","obo:HP_0000957"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7d1c61f5-10f1-4bfa-8400-f90d5be47308_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16000562","allele":{"id":"https://genegraph.clinicalgenome.org/r/f1413610-e65c-40e1-b8b3-5d04679f968e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000179.2(MSH6):c.3633dupT (p.Val1212Cysfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8941"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a6f50917-5bb4-4a35-a8bb-fd4ecdc0fa78_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A complex mutation, c.4002-31_4002-8delinsTTAAAAAAAAAAAAAAAAAAGTTT, was identified in both aberrant transcripts. This exchange of 24 nucleotides with their reverse complementary sequence causes loss of the polypyrimidine-tract at the 30 splice site of the terminal intron 9 (Fig. 1C) and, hence, explains the observed splicing defect. Immunohistochemical analysis revealed complete loss of MSH6 expression in the glioblastoma as well as the nonneoplastic vasculature interspersed into the neoplastic tissue of Patient 2.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82245147-241f-42ef-9b3c-fabc24330ffe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18030674","rdfs:label":"Patient 2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0004377","obo:HP_0100843","obo:HP_0002885","obo:HP_0000957"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a6f50917-5bb4-4a35-a8bb-fd4ecdc0fa78_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18030674","allele":{"id":"https://genegraph.clinicalgenome.org/r/984692a1-6bf6-42ff-afbf-0497e657a96a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000002.12:g.47806748_47806771delinsTTAAAAAAAAAAAAAAAAAAGTTT","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357262"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b7d02927-ac93-4a43-a86d-01cd381f4e9f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a657e7e2-5105-46e0-b326-2de81ccc4d13_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","rdfs:label":"Family G0415","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/a657e7e2-5105-46e0-b326-2de81ccc4d13","type":"Family","rdfs:label":"Family G0415","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/aed92b6d-a776-4d64-8298-1756bb2c1c55"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0100843","obo:HP_0000957","obo:HP_0005227"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/aed92b6d-a776-4d64-8298-1756bb2c1c55"}},{"id":"https://genegraph.clinicalgenome.org/r/0dc7bc43-020e-4938-97e9-df8588a56b38_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17259933","rdfs:label":"FACT17","estimatedLodScore":1.62,"family":{"id":"https://genegraph.clinicalgenome.org/r/0dc7bc43-020e-4938-97e9-df8588a56b38","type":"Family","rdfs:label":"FACT17","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fcccf36e-9e31-45ef-9ba8-6622ea551a1e"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":13,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0003003","obo:HP_0004808","obo:HP_0005227","obo:HP_0002885"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/fcccf36e-9e31-45ef-9ba8-6622ea551a1e"}},{"id":"https://genegraph.clinicalgenome.org/r/fe5cbfbb-427c-4d93-897a-cce84d3bd5bd_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15340263","rdfs:label":"Family","estimatedLodScore":1.37,"family":{"id":"https://genegraph.clinicalgenome.org/r/fe5cbfbb-427c-4d93-897a-cce84d3bd5bd","type":"Family","rdfs:label":"Family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c889501a-5d4c-4126-9d11-b60bb8af4bea"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":11,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0100706","obo:HP_0003003","obo:HP_0000957"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c889501a-5d4c-4126-9d11-b60bb8af4bea"}},{"id":"https://genegraph.clinicalgenome.org/r/82f907a9-cbdc-49db-9454-0678672e92d3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16000562","rdfs:label":"Turcot Syndrome family","estimatedLodScore":4.35,"family":{"id":"https://genegraph.clinicalgenome.org/r/82f907a9-cbdc-49db-9454-0678672e92d3","type":"Family","rdfs:label":"Turcot Syndrome family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e8a6c276-179c-4e1e-91a7-2a259623953c"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":30,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0040276","obo:HP_0012190","obo:HP_0000957","obo:HP_0000997"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e8a6c276-179c-4e1e-91a7-2a259623953c"}},{"id":"https://genegraph.clinicalgenome.org/r/723b4a28-0068-468d-9fc3-fb580b1c4c74_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16283678","rdfs:label":"Family M1","estimatedLodScore":4.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/723b4a28-0068-468d-9fc3-fb580b1c4c74","type":"Family","rdfs:label":"Family M1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/82a53402-98b8-404d-be54-5d77373d0cce"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":33,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0009592","obo:HP_0012190","obo:HP_0000997","obo:HP_0100843","obo:HP_0000957"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/82a53402-98b8-404d-be54-5d77373d0cce"}},{"id":"https://genegraph.clinicalgenome.org/r/0c062f64-9e88-4624-8be4-a07370632123_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18030674","rdfs:label":"Family I","family":{"id":"https://genegraph.clinicalgenome.org/r/0c062f64-9e88-4624-8be4-a07370632123","type":"Family","rdfs:label":"Family I","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/82245147-241f-42ef-9b3c-fabc24330ffe"}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0004377","obo:HP_0000957","obo:HP_0002885","obo:HP_0100843"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/82245147-241f-42ef-9b3c-fabc24330ffe"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/b7d02927-ac93-4a43-a86d-01cd381f4e9f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7d02927-ac93-4a43-a86d-01cd381f4e9f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82efa960-f62f-42a0-b019-0ae8d1e517b1","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8825792-7bda-424f-b567-b9b792a20fa8","type":"Finding","dc:description":"MSH6 -/- mutant zebrafish develop neurofibromas/malignant peripheral nerve sheath tumors and other tumors.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18593904","rdfs:label":"MMR-deficient zebrafish develop neurofibromas & other tumors","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3e78cae8-f14d-4dff-9de0-7c2539f85a27","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db8c6cf7-2e1f-456a-842a-ff7238b55cba","type":"Finding","dc:description":"Msh6 -/- mice have a significantly reduced life span. Msh6 mutant mice develop a spectrum of tumors, predominantly non-Hodgkin’s lymphoma (NHL) followed by tumors in the gastrointestinal (GI) tract.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9390556","rdfs:label":"Mutation in gene Msh6 causes cancer susceptibility","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/b7d02927-ac93-4a43-a86d-01cd381f4e9f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63d79080-eee9-40c6-af3e-a759cbf76d0a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b549cced-1208-4191-b9a9-42a11dcdc172","type":"Finding","dc:description":"Mismatch bound MutSa (MSH2 and MSH6) recruits a second heterodimer referred to as MutLa which is composed of the MutL homologs MLH1 and PMS2. MLH1 also causes constitutional mismatch repair deficiency syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9927034","rdfs:label":"MLH1 – constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9b29db19-f844-41c8-ae4e-0b60ef2ed70a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d11f9e9b-f331-4349-ac0a-9245acd6a358","type":"Finding","dc:description":"In humans mismatch recognition is mediated by one of two heterodimers, composed of the MutS homologs MSH2 and MSH6 (MutSa) or MSH2 and MSH3 (MutSb). MSH2 also causes constitutional mismatch repair deficiency syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11809679","rdfs:label":"MSH2 - constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f47e21f3-2667-41cb-aeaa-4b6112db71b4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45f51b27-8774-4a49-84f8-26a0977bcb08","type":"Finding","dc:description":"Mismatch bound MutSa (MSH2 and MSH6) recruits a second heterodimer referred to as MutLa which is composed of the MutL homologs MLH1 and PMS2. PMS2 also causes constitutional mismatch repair deficiency syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10763829","rdfs:label":"PMS2 – constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/54f91ddc-036a-4277-87f8-923b2b4fc1e1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e70a3ff1-720b-4ffd-8287-0322df07fd92","type":"Finding","dc:description":"Immunohistochemical analysis revealed complete loss of MSH6 expression in the glioblastoma as well as the nonneoplastic vasculature interspersed into the neoplastic tissue of Patient 2 (Supplementary Fig. S1)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18030674","rdfs:label":"IHC analysis revealed complete loss of MSH6 expression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8d134f9a-9da1-43fe-84f2-71ea221f849c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/401173d4-43c9-4ea6-8fe2-7e27283ef03d","type":"Finding","dc:description":"Immunohistochemistry staining revealed a total absence of MSH6 protein in both neoplastic and normal colon epithelial tissues. The constitutional inactivation of MSH6 was further evidenced by western blot analysis (Fig. 2A), which demonstrated a total absence of MSH6 protein in the patient’s lymphocytes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","rdfs:label":"IHC and western blot revealed absence of MSH6 protein","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":333,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/b5PiZgvHKf8","type":"GeneValidityProposition","disease":"obo:MONDO_0010159","gene":"hgnc:7329","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_b7d02927-ac93-4a43-a86d-01cd381f4e9f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}